$21.19 -0.6 -2.7%
Last Trade - 07/09/18
Market Cap | £n/a |
Enterprise Value | £n/a |
Revenue | £7.29bn |
Position in Universe | th / 6852 |
Oct 26 (Reuters) - RELX NV RELN.AS : * UNDERLYING REVENUE GROWTH +4% IN FIRST NINE MONTHS OF 2017 * FULL YEAR OUTLOOK IN SCIENTIFIC, TECHNICAL & MEDICAL: WE CONTINUE TO EXPECT MODEST UNDERLYING REVENUE GROWTH ( * FULL YEAR OUTLOOK IS UNCHANGED Source text for Eikon: ID:nNDL3P1wNX See also: urn:newsml:reuters.com:*:nFWN1N107C Further company coverage: RELN.AS (Gdynia Newsroom:) ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))